Overview
- Novo Nordisk says the 1.5 mg starter dose is now stocked at roughly 70,000 locations, including CVS and Costco, and through telehealth partners such as Ro, LifeMD, Weight Watchers, GoodRx and its NovoCare Pharmacy, with higher doses arriving within days.
- Cash prices are set at $149 per month for 1.5 mg, $149 for 4 mg through April 15 before rising to $199, and $299 for 9 mg and 25 mg, while eligible insured patients may pay as little as $25 monthly.
- The pill contains semaglutide, the same active ingredient as the injectables Wegovy and Ozempic, and carries an FDA indication to reduce major cardiovascular events in adults with obesity and established cardiovascular disease.
- Patients must take the tablet on an empty stomach with a small amount of water and wait about 30 minutes before eating, drinking or taking other medicines.
- Phase 3 results showed average weight loss of about 14%—rising to roughly 17% among those who stayed on treatment—while Eli Lilly’s competing oral orforglipron remains under FDA review with a decision expected later in 2026.